Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02896400 · ClinicalTrials.gov registry record · Phase 3
Optimizing Tobacco Dependence Treatment in the Emergency Department
A Phase 3 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,056
- Enrollment target
NCT02896400: Completed Phase 3 study, sponsored by Yale University.
NCT02896400 is a Phase 3 study that has completed, run by Yale University. The registered enrollment target is 1,056 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (37% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02896400, a Phase 3 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,056 participants
- Enrollment target
Study Summary
The investigators propose an innovative full-factorial design in a cohort of 1056 adult smokers in an urban emergency department (ED), to test the efficacy of four key intervention components: motivational interviewing, medication, quitline referral, and texting. At the trial's completion, a mixed-methods approach will be used to identify the components that were efficacious within the proposed cost constraint, along with feasibility and acceptability to providers and subjects. The investigators will then assemble an intervention that maximizes efficacy, given a cost-effectiveness constraint and findings from a qualitative analysis.
Primary Outcome
Abstinence self reported and verified by exhaled carbon monoxide
Interventions
- BEHAVIORAL Brief Negotiated Interview (BNI)
- DRUG Nicotine replacement therapy (NRT)
- OTHER CT Smokers Quitline (QL)
- OTHER SmokefreeText (Text)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,056 participants |
| Start Date | 2017-02-13 |
| Est. Completion | 2019-08-14 |
| Phase | Phase 3 |
What the finished NCT02896400 record still lists
NCT02896400 is an interventional study that assigns participants to a tested intervention. Its 1,056 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (37% higher).
The record links to 0 conditions, and to 4 interventions - of which Brief Negotiated Interview (BNI) is the first listed.
NCT02896400 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02896400 about?
NCT02896400 is a clinical study titled "Optimizing Tobacco Dependence Treatment in the Emergency Department". The investigators propose an innovative full-factorial design in a cohort of 1056 adult smokers in an urban emergency department (ED), to test the efficacy of four key intervention components: motivational interviewing, medication, quitline referral, and texting. At the trial's completion, a mixed-m...
What is the current status of trial NCT02896400?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,056 participants. The study started on 2017-02-13. Estimated completion is 2019-08-14.
What interventions are being tested in trial NCT02896400?
The interventions under investigation include: Brief Negotiated Interview (BNI) (BEHAVIORAL), Nicotine replacement therapy (NRT) (DRUG), CT Smokers Quitline (QL) (OTHER), SmokefreeText (Text) (OTHER).
Who is sponsoring clinical trial NCT02896400?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02896400's enrollment target sits among peer trials
1,056 277th of 2000 higher than 1,724 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03242642 · 1,056 participants · NA
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- NCT04372108 · 1,056 participants
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- NCT07018869 · 1,057 participants · Phase 3
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- NCT03588286 · 1,058 participants · NA
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI